COVID-19 Induced Telogen Effluvium

NCT04834102 | Unknown DMC

• 1 other identifier: 2021/0123
• Study Type: observational
• Target: 200
• Locations: 1 country
• Sites: 1

Brief Summary

This study inquires about the development of Telogen effluvium following the SARS-CoV-2 infection

Conditions

Covid19; Telogen Effluvium; SARS-CoV Infection; Alopecia

Keywords

Telogen Effluvium; Covid-19; Alopecia

Outcome Measures

Primary Outcomes (1)

• Hair shedding

  Physical examination of hair and scalp, trichoscopy, hair pull test

  3 months

Interventions

Blood Tests DIAGNOSTIC_TEST

Evaluation of blood ferritin, hemoglobine, serum iron and serum iron binding capacity

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Adults that are diagnosed with COVID-19 in the past year.

You may qualify if:

• Sars-CoV-2 infection in the past year

You may not qualify if:

• Other common causes of Telogen effluvium ( such as anemia, iron deficiency, thyroid dysfunction)

Sponsors & Collaborators

• Istanbul Medeniyet University: lead

Study Sites (1)

Istanbul Medeniyet University

Istanbul, Kadıköy, 34720, Turkey (Türkiye)

RECRUITING

Related Publications (4)

• Asghar F, Shamim N, Farooque U, Sheikh H, Aqeel R. Telogen Effluvium: A Review of the Literature. Cureus. 2020 May 27;12(5):e8320. doi: 10.7759/cureus.8320.

  PMID: 32607303 RESULT

• Mieczkowska K, Deutsch A, Borok J, Guzman AK, Fruchter R, Patel P, Wind O, McLellan BN, Mann RE, Halverstam CP. Telogen effluvium: a sequela of COVID-19. Int J Dermatol. 2021 Jan;60(1):122-124. doi: 10.1111/ijd.15313. Epub 2020 Nov 23. No abstract available.

  PMID: 33226117 RESULT

• Rizzetto G, Diotallevi F, Campanati A, Radi G, Bianchelli T, Molinelli E, Mazzanti S, Offidani A. Telogen effluvium related to post severe Sars-Cov-2 infection: Clinical aspects and our management experience. Dermatol Ther. 2021 Jan;34(1):e14547. doi: 10.1111/dth.14547. Epub 2020 Nov 23.

  PMID: 33190397 RESULT

• Cline A, Kazemi A, Moy J, Safai B, Marmon S. A surge in the incidence of telogen effluvium in minority predominant communities heavily impacted by COVID-19. J Am Acad Dermatol. 2021 Mar;84(3):773-775. doi: 10.1016/j.jaad.2020.11.032. Epub 2020 Dec 10. No abstract available.

  PMID: 33310111 RESULT

MeSH Terms

Conditions

COVID-19; Severe Acute Respiratory Syndrome; Alopecia

Interventions

Hematologic Tests

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases; Hypotrichosis; Hair Diseases; Skin Diseases; Skin and Connective Tissue Diseases; Pathological Conditions, Anatomical; Pathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Clinical Laboratory Techniques; Diagnostic Techniques and Procedures; Diagnosis; Investigative Techniques

Study Officials

• Hasan AKSOY, Dr.

  Istanbul Medeniyet University

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Umut Mert YILDIRIM, Dr.

CONTACT

+905423383842; umutmertyildirim@gmail.com

Hasan AKSOY, Dr.

CONTACT

+905053005460; haxoil@yahoo.com

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Specialist Dr.

Study Record Dates

• First Submitted: April 4, 2021
• First Posted: April 6, 2021
• Study Start: January 27, 2021
• Primary Completion: April 27, 2021
• Study Completion: April 27, 2021
• Last Updated: April 6, 2021

Record last verified: 2021-04

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)